Antidote Case Study: IPF

Idiopathic pulmonary fibrosis (IPF) case study

United States

Download this case study to find out how Antidote delivered:

  • 600 eligible patients
  • 65% eligibility rate
  • 3 month project timeframe (versus anticipated 6 month)